Pausing for a picture during a two-day course on PETCT technology, hosted at Hammersmith Hospital in West London.
A dedicated two-day course designed to introduce and build knowledge of PETCT technology and procedures was successfully completed by 30 radiologists, physicists, and radiographers from the UK and Europe. It was hosted at Hammersmith Hospital, part of Imperial College Healthcare NHS Trust and managed by Siemens Healthcare.
The course discussed the innovation of PETCT scanners and biomarkers, while interactive sessions focused on the interpretation of scans featuring fludeoxyglucose (FDG) and novel tracers such as Gallium-68 DOTATATE. Lectures also covered the use of PETCT in lymphoma, lung cancer and respiratory gating, breast and melanoma.
Professor Adil Al-Nahhas, chief of service of nuclear medicine at Imperial College Healthcare NHS Trust, said: “This first PETCT course gave an overview on the physics and radiopharmacy of PETCT and explained the modern role in diagnosis, staging and response to therapy.”
See this report on page 3 of the December 2010 issue of RAD Magazine.